119 related articles for article (PubMed ID: 10765112)
1. Enalapril inhibits growth and proliferation of various tissues in rat normotensive four-sixths kidney ablation nephropathy.
Gajdos M; Krivosíková Z; Sebeková K; Lajdová I; Spustová V; Dzúrik R
Kidney Blood Press Res; 2000; 23(2):106-12. PubMed ID: 10765112
[TBL] [Abstract][Full Text] [Related]
2. Enalapril in subantihypertensive dosage attenuates kidney proliferation and functional recovery in normotensive ablation nephropathy of the rat.
Krivosíková Z; Sebeková K; Spustová V; Lajdová I; Dzúrik R
Physiol Res; 1999; 48(6):429-35. PubMed ID: 10783907
[TBL] [Abstract][Full Text] [Related]
3. Treatment with enalapril and not diltiazem ameliorated progression of chronic kidney disease in rats, and normalized renal AT1 receptor expression as measured with PET imaging.
Ismail B; deKemp RA; Croteau E; Hadizad T; Burns KD; Beanlands RS; DaSilva JN
PLoS One; 2017; 12(5):e0177451. PubMed ID: 28542215
[TBL] [Abstract][Full Text] [Related]
4. A combination of Chinese herbs, Astragalus membranaceus var. mongholicus and Angelica sinensis, improved renal microvascular insufficiency in 5/6 nephrectomized rats.
Song J; Meng L; Li S; Qu L; Li X
Vascul Pharmacol; 2009; 50(5-6):185-93. PubMed ID: 19563735
[TBL] [Abstract][Full Text] [Related]
5. Vasopeptidase inhibitor restores the balance of vasoactive hormones in progressive nephropathy.
Benigni A; Zoja C; Zatelli C; Corna D; Longaretti L; Rottoli D; Maggioni P; Todeschini M; Noris M; Remuzzi G
Kidney Int; 2004 Nov; 66(5):1959-65. PubMed ID: 15496167
[TBL] [Abstract][Full Text] [Related]
6. Curcumin ameliorates renal failure in 5/6 nephrectomized rats: role of inflammation.
Ghosh SS; Massey HD; Krieg R; Fazelbhoy ZA; Ghosh S; Sica DA; Fakhry I; Gehr TW
Am J Physiol Renal Physiol; 2009 May; 296(5):F1146-57. PubMed ID: 19225048
[TBL] [Abstract][Full Text] [Related]
7. Effects of antihypertensive therapy on intrarenal angiotensin and bradykinin levels in experimental renal insufficiency.
Mackie FE; Meyer TW; Campbell DJ
Kidney Int; 2002 Feb; 61(2):555-63. PubMed ID: 11849396
[TBL] [Abstract][Full Text] [Related]
8. Erythropoietin combined with ACE inhibitor prevents heart remodeling in 5/6 nephrectomized rats independently of blood pressure and kidney function.
Gut N; Piecha G; Aldebssi F; Schaefer S; Bekeredjian R; Schirmacher P; Ritz E; Gross-Weissmann ML
Am J Nephrol; 2013; 38(2):124-35. PubMed ID: 23920063
[TBL] [Abstract][Full Text] [Related]
9. Combination of exercise and enalapril enhances renoprotective and peripheral effects in rats with renal ablation.
Kanazawa M; Kawamura T; Li L; Sasaki Y; Matsumoto K; Kataoka H; Ito O; Minami N; Sato T; Ootaka T; Kohzuki M
Am J Hypertens; 2006 Jan; 19(1):80-6. PubMed ID: 16461196
[TBL] [Abstract][Full Text] [Related]
10. Vitamin D receptor agonist VS-105 improves cardiac function in the presence of enalapril in 5/6 nephrectomized rats.
Wu-Wong JR; Chen YW; Wessale JL
Am J Physiol Renal Physiol; 2015 Feb; 308(4):F309-19. PubMed ID: 25503724
[TBL] [Abstract][Full Text] [Related]
11. Analysis of growth in five-sixths-nephrectomized rats.
Santos F; Cobo A; Orejas G; Martínez V; Rey C; Málaga S; Crespo M
Miner Electrolyte Metab; 1996; 22(1-3):83-7. PubMed ID: 8676833
[TBL] [Abstract][Full Text] [Related]
12. Kidney function in rats after 5/6 nephrectomy (5/6 NX); effort of treatment with vitamin E.
Bräunlich H; Marx F; Fleck C; Stein G
Exp Toxicol Pathol; 1997 Feb; 49(1-2):135-9. PubMed ID: 9085088
[TBL] [Abstract][Full Text] [Related]
13. Pharmacologic nephrectomy with chronic angiotensin converting enzyme inhibitor treatment in renovascular hypertension in the rat.
Jackson B; Franze L; Sumithran E; Johnston CI
J Lab Clin Med; 1990 Jan; 115(1):21-7. PubMed ID: 2299253
[TBL] [Abstract][Full Text] [Related]
14. V1/V2 Vasopressin receptor antagonism potentiates the renoprotection of renin-angiotensin system inhibition in rats with renal mass reduction.
Perico N; Zoja C; Corna D; Rottoli D; Gaspari F; Haskell L; Remuzzi G
Kidney Int; 2009 Nov; 76(9):960-7. PubMed ID: 19625993
[TBL] [Abstract][Full Text] [Related]
15. Enalapril reduces the expression of nuclear factor-kappaB and c-Jun N-terminal kinase in the renal cortices of five-sixths-nephrectomized rats.
Costa JC; Costa RS; Silva CG; Coimbra TM
Am J Nephrol; 2006; 26(3):281-6. PubMed ID: 16772709
[TBL] [Abstract][Full Text] [Related]
16. The effect of oral protease administration in the rat remnant kidney model.
Sebeková K; Dämmrich J; Krivosíková Z; Heidland A
Res Exp Med (Berl); 1999 Dec; 199(3):177-88. PubMed ID: 10639701
[TBL] [Abstract][Full Text] [Related]
17. [The effect of a low-protein diet and certain pharmaceutical agents on the course of ablation nephropathy in rats].
Heller J; Cervenka L; Hellerová S
Cas Lek Cesk; 1994 Jul; 133(14):429-33. PubMed ID: 8069900
[TBL] [Abstract][Full Text] [Related]
18. The role of angiotensin-II in progressive diabetic glomerulopathy in the rat.
Whiteside CI; Thompson J
Endocrinology; 1989 Oct; 125(4):1932-40. PubMed ID: 2551633
[TBL] [Abstract][Full Text] [Related]
19. Comparison of enalapril and valsartan in cyclosporine A-induced hypertension and nephrotoxicity in spontaneously hypertensive rats on high-sodium diet.
Lassila M; Finckenberg P; Pere AK; Krogerus L; Ahonen J; Vapaatalo H; Nurminen ML
Br J Pharmacol; 2000 Jul; 130(6):1339-47. PubMed ID: 10903974
[TBL] [Abstract][Full Text] [Related]
20. Effects of enalapril on the expression of cardiac angiotensin-converting enzyme and angiotensin-converting enzyme 2 in spontaneously hypertensive rats.
Yang Z; Yu X; Cheng L; Miao LY; Li HX; Han LH; Jiang WP
Arch Cardiovasc Dis; 2013 Apr; 106(4):196-201. PubMed ID: 23706365
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
